Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Patient and Stakeholder Engagement Rare Cancer Research from the Patient’s POV By Premier Research January 20, 2017 Clinical ResearchPhase 1 - Phase 4 Biomarker Method Validation in Rare Disease Drug Development By Premier Research January 19, 2017 Clinical ResearchPhase 1 - Phase 4 3 Innovations Improving Neuropsychological Testing in CNS Drug Development By Krista Armstrong January 16, 2017 Clinical ResearchPhase 1 - Phase 4 The Why, What, and How of the Current State of CNS Drug Development By Krista Armstrong January 13, 2017 Medical and Regulatory Affairs 8 Programs That Get Rare Cancer Treatments to Patients Faster By Premier Research January 13, 2017 Clinical ResearchPhase 1 - Phase 4 Want to Study Rare Disease? Get Ready for These Roadblocks By Angi Robinson January 12, 2017 Previous 1 …51 52 53 54 55 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today